Replies to post #28337 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[1manband]

That is really not believable. If that were even slightly true, Rock Creek would have had ZERO trouble in attracting a partner for its development/commercialization, if not an outright buyout.

But it didn't. Instead, Rock Creek racked up about $60 million in liabilities and had to go Chapter 7. Liquidation. And there is absolutely no evidence, based on the court filings to date, that there are any significant bidders for the technology.